1. 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. (September 2015) Authors: Gullo, G.; Kennedy, J.; Breathnach, O.; McCaffrey, J.; Keane, M.; Martin, M.; Gupta, R.; Leonard, G.; Calvert, P.; Donnellan, P.; Walshe, J.; Mc Dermott, E.; Cairney, S.; Bose, R.; Scott, K.; Hernando, A.; Parker, I.; Tryfonopoulos, D.; Moulton, B.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3339 The impact of body composition parameters on ipilimumab toxicity in metastatic melanoma and longitudinal changes in body composition during treatment. (September 2015) Authors: Daly, L.; O'Reilly, A.; Donnellan, P.; Cushen, S.; Woodlock, D.; Twomey, M.; Ryan, A.; Power, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liquid air energy storage systems: A review. (August 2021) Authors: O'Callaghan, O.; Donnellan, P. Journal: Renewable & sustainable energy reviews Issue: Volume 146(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MON-PP004: The Impact of Body Composition Parameters on Ipilimumab Toxicity in Metastatic Melanoma and Longitudinal Changes in Body Composition During Treatment. (September 2015) Authors: Daly, L.E.; O'Reilly, A.; Donnellan, P.; Cushen, S.; Woodlock, D.; Power, D.; Aoife, R. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗